Gregory Alan Korbel

APRE

Gregory Alan Korbel serves as SVP, Chief Operating Officer at Aprea Therapeutics, Inc. (APRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

9 trades

$569.9K

Net Position

Net Seller

$569.9K

Companies Traded

APRE

Active Period

Aug 2021 – Jun 2022

9 total trades

Most Recent

Sell APRE

Jun 3, 2022 · $6.8K

Gregory Alan Korbel's Insider Trading at Aprea Therapeutics, Inc. (APRE)

Buys

0 · $0.00

Sells

9 · $569.9K

Total Shares Bought

Total Shares Sold

130,038

APRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jun 3, 2022	Sell	8,390	$0.81	$6.8K
Mar 10, 2022	Sell	1,989	$1.82	$3.6K
Feb 25, 2022	Sell	1,326	$1.74	$2.3K
Dec 1, 2021	Sell	27,500	$3.96	$108.9K
Nov 1, 2021	Sell	27,500	$5.00	$137.5K
Oct 1, 2021	Sell	27,500	$4.89	$134.5K
Sep 20, 2021	Sell	32,960	$4.97	$163.9K
Sep 10, 2021	Sell	1,724	$4.59	$7.9K
Aug 25, 2021	Sell	1,149	$3.98	$4.6K

Related Insiders

Oren Gilad

President/CEO

APREBuy · Jan 30, 2026

John P. Hamill

SrVP/CFO/Prin Fin & Acct Ofcr

APREBuy · Jan 30, 2026

Marc Duey

Director

APREBuy · Dec 10, 2025

Explore More Insider Trading Data

APRE Insider Trading Activity

View all insider trades at Aprea Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity